Brain-derived neurotrophic factor regulates the expression of D1 dopamine receptors

Journal of Neurochemistry

Volumn 100, Issue 2, 2007, Pages 416-428

  Do, Thuy ^a   Kerr, Bredford ^b   Kuzhikandathil, Eldo V ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adenylyl cyclase; Differentiation; Neurotrophin; Signal transduction; Transcription; Translation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DACTINOMYCIN; DOPAMINE 1 RECEPTOR; ETICYCLIDINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; GENE DELETION; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HOMOZYGOSITY; KNOCKOUT MOUSE; MALE; MODEL; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOLAMINES; CELL DIFFERENTIATION; CELL LINE; CLONING, MOLECULAR; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; RECEPTOR, TRKA; RECEPTOR, TRKB; RECEPTORS, DOPAMINE D1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX FACTORS; TRANSFECTION;

EID: 33845801593     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04249.x     Document Type: Article

References (64)

1. Alcantara S., Frisen J., del Rio J. A., Soriano E., Barbacid M. and Silos-Santiago I. (1997) TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J. Neurosci. 17, 3623-3633.
2. Altar C. A. and Distefano P. S. (1998) Neurotrophin trafficking by anterograde transport. Trends Neurosci. 21, 433-437.
3. 1B receptor in central nervous system using anti-receptor antisera. Brain Res. 746, 141-150.
4. 1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann. Neurol. 57, 17-26.
5. 2 receptor gene expression in the striatum in Huntington's disease. Ann. Neurol. 42, 215-221.
6. Barbacid M. (1995) Structural and functional properties of the TRK family of neurotrophin receptors. Ann. N. Y. Acad. Sci. 766, 442-458.
7. Berke J. and Hyman S. (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25, 515-532.
8. 1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 3, 492-498.
9. 5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling. Glia 46, 284-295.
10. Butkerait P. and Friedman E. (1993) Repeated reserpine increases striatal dopamine receptor and guanine nucleotide binding protein RNA. J. Neurochem. 60, 566-571.
11. Chao M. V. (2003) Neurotrophins and their receptors: a convergence point for many signaling pathways. Nat. Rev. Neurosci. 4, 299-309.
12. Civelli O., Bunzow J. R. and Grandy D. K. (1993) Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 33, 281-307.
13. Davies A. M. and Wright E. M. (1995) Neurotrophic factors. Neurotrophin autocrine loops. Curr. Biol. 5, 723-726.
14. 1 dopamine receptor. Nature 347, 72-76.
15. Encinas M., Iglesias M., Llecha N. and Comella J. X. (1999) Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem. 73, 1409-1421.
16. Fan G., Egles C., Sun Y., Minichiello L., Renger J. J., Klein R., Liu G. and Jaenisch R. (2000) Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activities. Nat. Neurosci. 3, 350-357.
17. Ferrer I., Goutan E., Marin C., Rey M. J. and Ribalta T. (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res. 866, 257-261.
18. Fumagalli F., Santero R., Gennarelli M., Giorgio R. and Andrea R. M. (2001) Decreased hippocampal BDNF expression after acute systemic injection of quinpirole. Neuropharmacology 40, 954-957.
19. Ginovart N., Lundin A., Farde L., Halldin C., Backman L., Swahn C. G., Pauli S. and Sedvall G. (1997) PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 120, 503-514.
20. 3H-SCH 23390: decrease in the striatum of aged rat. Neurobiol. Aging 8, 51-54.
21. 3 receptor expression and triggers behavioural sensitization. Nature 41, 86-89.
22. Hemby S. E., Trojanowski J. Q. and Ginsberg S. D. (2003) Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. J. Comp. Neurol. 456, 176-183.
23. Horton C. D., Qi Y., Chikaraishi D. and Wang J. K. (2001) Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line. J. Neurochem. 76, 201-209.
24. Howells D. W., Porritt M. J., Wong J. Y., Batchelor P. E., Kalnins R., Hughes A. J. and Donnan G. A. (2000) Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp. Neurol. 166, 127-135.
25. Huang E. J. and Reichardt L. F. (2003) TrK receptors: roles in neuronal signal transduction. Ann. Rev. Biochem. 72, 609-642.
26. Hwang C. K., D'Souza U. M., Eisch A. J., Yajima S., Lammers C. H., Yang Y., Lee S. H., Kim Y. M., Nestler E. J. and Mouradian M. M. (2001) Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor. Proc. Natl Acad. Sci. USA 98, 7558-7563.
27. Ip N. Y., Ibanez C. F., Nye S. H. et al. (1992) Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl Acad. Sci. USA 89, 3060-3064.
28. Ip N. Y., Stitt T. N., Tapley P., Klein R., Glass D. J., Fandl J., Greene L. A., Barbacid M. and Yancopoulos G. D. (1993) Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and non-neuronal cells. Neuron 10, 137-149.
29. Jones K. R., Farinas I., Backus C. and Reichardt L. F. (1994) Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76, 989-999.
30. Jung A. B. and Bennett J. P. Jr (1996) Developmental of striatal dopaminergic function. III: Pre- and postnatal development of striatal and cortical mRNAs for the neurotrophin receptors trkBTK+ and trkC and their regulation by synaptic dopamine. Brain Res. Dev. Brain Res. 94, 133-143.
31. Kaplan D. R. and Miller F. D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381-391.
32. Kuppers E. and Beyer C. (2001) Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. Neuroreport 12, 1175-1179.
33. Lai H., Bowden D. M. and Horita A. (1998) Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the rhesus monkey (Macaca mulatta). Neurobiol. Aging 8, 45-49.
34. Lamballe F., Klein R. and Barbacid M. (1991) trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66, 967-979.
35. Laurier L. G., Corrigall W. A. and George S. R. (1994) Dopamine receptor density, sensitivity and mRNA levels are altered following self-administration of cocaine in the rat. Brain Res. 634, 31-40.
36. Missale C., Nash S. R., Robinson S. W., Jaber M. and Caron M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225.
37. Mogi M., Togari A., Kondo T., Mizuno Y., Komure O., Kuno S., Ichinose H. and Nagatsu T. (1999) Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci. Lett. 270, 45-48.
38. 2 receptors. Neuroscience 36, 403-410.
39. 2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Mol. Pharmacol. 50, 1073-1079.
40. Numan S. and Seroogy K. B. (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403, 295-308.
41. 1A dopamine receptor gene transcription by Brn-4. Proc. Natl Acad. Sci. USA 93, 11 933-11 938.
42. Paredes A., Romero C., Dissen G. A., Dechiara T. M., Reichardt L., Cornea A., Ojeda S. R. and Xu B. (2004) TrkB receptors are required for follicular growth and oocyte survival in the mammalian ovary. Dev. Biol. 267, 430-449.
43. 1 dopamine receptor expression and function in the CAD catecholaminergic cell line. J. Neurochem. 89, 1508-1519.
44. Patapoutian A. and Reichardt L. F. (2001) Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11, 272-280.
45. Pineda J. R., Canals J. M., Bosch M., Adell A., Mengod G., Artigas F., Ernfors P. and Alberch J. (2005) Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease. J. Neurochem. 93, 1057-1068.
46. 2 receptor mRNA in rat striatum by chronic neuroleptic treatment. Eur. J. Pharmacol. 207, 165-168.
47. Rohrer B., Korenbrot J. I., Lavail M. M., Reichardt L. F. and Xu B. (1999) Role of neurotrophin receptor TrkB in the maturation of rod photoreceptors and establishment of synaptic transmission to the inner retina. J. Neurosci. 19, 8919-8930.
48. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62, 65-85.
49. Severson J. A. and Finch C. E. (1980) Reduced dopaminergic binding during agin in the rodent striatum. Brain Res. 192, 147-162.
50. Sibley D. R., Monsma F. J. Jr and Shen Y. (1993) Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 35, 391-415.
51. Soppet D., Escandon E., Maragos J. et al. (1991) The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65, 895-903.
52. Squinto S. P., Stitt T. N., Aldrich T. H. et al. (1991) trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65, 885-893.
53. Stoessl A. J. and de la Fuente-FernandezR. (2003) Dopamine receptors in Parkinson's disease: imaging studies. Adv. Neurol. 91, 65-71.
54. 2-like receptor binding in the F344/N rat striatum revealed by position emission tomography and in vitro receptor autoradiography. Synapse 41, 285-293.
55. 1A dopamine receptor gene transcription in neuro2a cells. Brain Res. Mol. Brain Res. 74, 208-216.
56. Vallone D., Picetti R. and Borrelli E. (2000) Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 24, 125-132.
57. 1 receptors in human brain: a PET study. Synapse 30, 56-61.
58. Webster M. J., Herman M. M., Kleinman J. E. and Weickert S. C. (2006) BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr. Patterns 6, 941-951.
59. 2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann. Neurol. 40, 49-54.
60. 2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. Life Sci. 50, 383-396.
61. Yan Q., Radeke M. J., Matheson C. R., Talvenheimo J., Welcher A. A. and Feinstein S. C. (1997) Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J. Comp. Neurol. 378, 135-157.
62. Yang Y., Hwang C. K., D'Souza U. M., Lee S. H., Junn E. and Mouradian M. M. (2000a) Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription. J. Biol. Chem. 275, 20 734-20 741.
63. 1A dopamine receptor gene. J. Biol. Chem. 275, 38 863-38 869.
64. Zuccato C., Ciammola A., Rigamonti D. et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498.